Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5,071,025
-
Total 13F shares
-
19,038,767
-
Share change
-
+1,007,426
-
Total reported value
-
$3,796,416,375
-
Put/Call ratio
-
15613%
-
Price per share
-
$199.34
-
Number of holders
-
270
-
Value change
-
+$212,751,881
-
Number of buys
-
150
-
Number of sells
-
107
Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2017
As of 31 Mar 2017,
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by
270 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,038,767 shares.
The largest 10 holders included
ATLANTA CAPITAL MANAGEMENT CO L L C, BlackRock Inc., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Corvex Management LP, ARIEL INVESTMENTS, LLC, TimesSquare Capital Management, LLC, STATE STREET CORP, UBS ASSET MANAGEMENT AMERICAS INC, and FORT WASHINGTON INVESTMENT ADVISORS INC /OH/.
This page lists
270
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.